![](/img/cover-not-exists.png)
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
Chen, Ying, You, Fengtao, Jiang, Licui, Li, Jialu, Zhu, Xuejun, Bao, Yangyi, Sun, Xiang, Tang, Xiaowen, Meng, Huimin, An, Gangli, Zhang, Bozhen, Yang, LinVolume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.16201
Date:
June, 2017
File:
PDF, 3.24 MB
english, 2017